BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8894739)

  • 21. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
    Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
    Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
    Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose and oxygen hypometabolism in aceruloplasminemia brains.
    Miyajima H; Takahashi Y; Kono S; Sugimoto M; Suzuki Y; Hishida A; Sakamoto M; Ouchi Y
    Intern Med; 2002 Mar; 41(3):186-90. PubMed ID: 11929178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary ceruloplasmin deficiency with hemosiderosis.
    Okamoto N; Wada S; Oga T; Kawabata Y; Baba Y; Habu D; Takeda Z; Wada Y
    Hum Genet; 1996 Jun; 97(6):755-8. PubMed ID: 8641692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia.
    Miyajima H; Adachi J; Tatsuno Y; Takahashi Y; Fujimoto M; Kaneko E; Gitlin JD
    Neurology; 1998 Jan; 50(1):130-6. PubMed ID: 9443469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aceruloplasminemia (hereditary ceruloplasmin deficiency) and diabetes mellitus].
    Momoki T; Terauchi Y
    Nihon Rinsho; 2006 Sep; Suppl 3():100-4. PubMed ID: 17022509
    [No Abstract]   [Full Text] [Related]  

  • 28. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene.
    Hatanaka Y; Okano T; Oda K; Yamamoto K; Yoshida K
    Intern Med; 2003 Jul; 42(7):599-604. PubMed ID: 12879954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis.
    Yazaki M; Yoshida K; Nakamura A; Furihata K; Yonekawa M; Okabe T; Yamashita N; Ohta M; Ikeda S
    J Neurol Sci; 1998; 156(1):30-4. PubMed ID: 9559983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR
    Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
    Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
    Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR imaging of cerebral cortical involvement in aceruloplasminemia.
    Grisoli M; Piperno A; Chiapparini L; Mariani R; Savoiardo M
    AJNR Am J Neuroradiol; 2005 Mar; 26(3):657-61. PubMed ID: 15760883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aceruloplasminemia.
    Gitlin JD
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Criteria for early identification of aceruloplasminemia.
    Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
    Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
    Parks NE; Vandorpe RA; Moeller JJ
    Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
    Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
    Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation.
    Miyajima H; Kono S; Takahashi Y; Sugimoto M; Sakamoto M; Sakai N
    Neurology; 2001 Dec; 57(12):2205-10. PubMed ID: 11756598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.